Abstract
In April 2021, we assessed mRNA vaccine effectiveness (VE) in the context of a COVID-19 outbreak in a skilled nursing facility. Among 28 cases, genomic sequencing was performed on 4 specimens on 4 different patients, and all were classified by sequence analysis as the Beta (B.1.351) variant. Adjusted VE among residents was 65% (95% confidence interval: 25-84%). These findings underscore the importance of vaccination for prevention of COVID-19 in skilled nursing facilities.
Keywords: SARS-CoV-2; skilled nursing facility; vaccine effectiveness.
All Keywords
【저자키워드】 SARS-CoV-2, skilled nursing facility, vaccine effectiveness, 【초록키워드】 Vaccine, vaccination, mRNA vaccine, B.1.351, variant, COVID-19 outbreak, Sequence analysis, Effectiveness, Beta, patients, genomic sequencing, specimen, prevention of COVID-19, was performed, 【제목키워드】 COVID-19, B.1.351, coronavirus 2, mRNA, Nursing, Beta, respiratory, Virginia, Against,
【저자키워드】 SARS-CoV-2, skilled nursing facility, vaccine effectiveness, 【초록키워드】 Vaccine, vaccination, mRNA vaccine, B.1.351, variant, COVID-19 outbreak, Sequence analysis, Effectiveness, Beta, patients, genomic sequencing, specimen, prevention of COVID-19, was performed, 【제목키워드】 COVID-19, B.1.351, coronavirus 2, mRNA, Nursing, Beta, respiratory, Virginia, Against,